← Immunocore Holdings plc IMCR
Market Price
$34.23
Market Cap
$1.74B
P/E Ratio
N/A
Revenue (FY 2025)
↑29.0% YoY
$400.02M
Full year reported
Net Income
↑30.5% YoY
-$35.51M
Net Margin: -8.9%
Free Cash Flow
↓-172.1% YoY
-$15.05M
FCF Yield: -0.87%
EPS (Diluted)
↑30.4% YoY
$-0.71
Basic: $-0.71
Return on Equity
Efficiency
-9.3%
ROA: -3.3%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (IMCR)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2018 | $23.7M | — | $5.9M | $-88.2M | — | $-3.32 | — | $-16.6M | $-20.1M | — |
| FY 2019 | $0.2M | -99.2% | $6.4M | $-126.2M | -43.1% | $-4.66 | -40.4% | $-101.4M | $-105.5M | -424.3% |
| FY 2020 | $0.5M | +148.6% | $7.5M | $-87.4M | +30.8% | $-2.79 | +40.1% | $-60.6M | $-63.6M | +39.6% |
| FY 2021 | $0.1M | -76.5% | $6.6M | $-140.9M | -61.3% | $-3.10 | -11.1% | $-96.1M | $-97.1M | -52.6% |
| FY 2022 | — | -100.0% | $143.3M | $-44.1M | +68.7% | $-0.90 | +71.0% | $-25.9M | $-27.7M | +71.5% |
| FY 2023 | $238.7M | — | $233.6M | $-55.3M | -25.2% | $-1.13 | -25.6% | $2.9M | $-2.5M | +91.0% |
| FY 2024 | $310.2M | +29.9% | $291.4M | $-51.1M | +7.6% | $-1.02 | +9.7% | $26.1M | $20.9M | +940.6% |
| FY 2025 | $400.0M | +29.0% | $387.9M | $-35.5M | +30.5% | $-0.71 | +30.4% | $-10.7M | $-15.1M | -172.1% |
Valuation
Market Price
$34.23
Market Cap
$1.74B
Enterprise Value
$1.71B
P/E Ratio
N/A
P/B Ratio
4.57
FCF Yield
-0.87%
Dividend Yield
0.00%
Shares Outstanding
Profitability & Margins
Gross Margin
96.96%
Operating Margin
-11.34%
Net Margin
-8.88%
Return on Equity (ROE)
-9.32%
Return on Assets (ROA)
-3.33%
Asset Turnover
0.37x
Revenue 3-Yr CAGR
N/A
Financial Health & Liquidity
Current Ratio
0.20
Cash Ratio
1.90
Debt / Equity
1.146
Debt / Assets
0.409
Cash & Equivalents
$467.71M
Total Debt
$436.69M
Book Value / Share
$7.49
Cash Flow Efficiency
Operating Cash Flow
-$10.71M
Capital Expenditures (CapEx)
$4.34M
Free Cash Flow
-$15.05M
OCF / Revenue
-2.68%
FCF / Revenue
-3.76%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.71
EPS (Basic)
$-0.71
Dividends / Share
N/A
Book Value / Share
$7.49
EPS YoY Growth
30.39%
Balance Sheet (FY 2025)
Total Assets
$1.07B
Total Liabilities
$686.24M
Stockholders' Equity
$381.03M
Current Assets
$50.05M
Current Liabilities
$246.70M